Shares of ICICI Life Insurance Ltd have fallen 34% in 2026, but Religare Broking has maintained a 'Buy' rating with a target price of ₹650, implying a 42.6% upside from the closing price of ₹456 on October 14. This outlook follows the insurer’s September-quarter results and reflects confidence in the company’s growth prospects, according to livemint.com.
Religare highlighted ICICI Life Insurance’s leadership transition, including the appointment of Siddharth Mishra as Managing Director and CEO, and the company’s rebranding as key factors supporting strategic continuity. The brokerage emphasized the insurer’s focus on customer-centricity, deeper penetration of micro-markets, and proprietary distribution channels. It also views the Insurance Regulatory and Development Authority of India’s consultation paper on distribution economics positively, expecting enhanced renewal commission allowances to align interests among distributors, policyholders, and insurers.
The brokerage noted that ICICI Life Insurance’s lean cost structure should help mitigate potential impacts from industry-wide changes in distribution economics. However, it expects near-term softness in market-linked savings products and a normalization in retail protection growth after four quarters of strong expansion. The company’s operating efficiency and distribution strategy remain central to its growth outlook, positioning it well among peers in the insurance sector.
Religare’s target price of ₹650 represents a substantial upside from the current market price, underscoring confidence in ICICI Life Insurance’s strategic initiatives and market position. The company’s next earnings update will provide further clarity on its performance trajectory, as noted by livemint.com.